Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-019898

General Counsel sold 946 shares at $6.53 ($6,175)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-16 Sale : show line 1 in the form −946 $6.53 $6,175 149,750 D
Open-market sales · 946 sh · avg $6.53 · $6,175
Loading xslF345X05/form4.xml…